Fig. 2From: Two-year clinical and radiographic evaluation of ACTIVA BioACTIVE versus Compomer (Dyract® eXtra) in the restoration of class-2 cavities of primary molars: a non-inferior split-mouth randomised clinical trialClinical evaluation based on USPHS Ryge Criteria at 6, 12, 18, and 24 months. Score A represents the ideal clinical situation, score B represents a clinically acceptable situation, and score C represents failure. Both groups had a significant difference regarding colour match (P = 0.002) and marginal discolouration (P = 0.0143)Back to article page